Unprecedented analysis of proteins and metabolites in patient serum provides new biomarkers associated with a patient’s risk of dying from Staphylococcus aureus bacteremia
UC San Diego Health will be part of the Phase III national AstraZeneca clinical trial that will recruit up to 30,000 participants at multiple sites across the country to assess the safety and efficacy of a vaccine to prevent COVID-19.
Unprecedented analysis of proteins and metabolites in patient serum provides new biomarkers associated with a patient’s risk of dying from Staphylococcus aureus bacteremia.
UC San Diego Health is now offering a new minimally invasive approach to provide relief for patients suffering from chronic low back pain). The new treatment is called “Intracept,” an outpatient procedure that targets nerves located in the vertebrae or bones of the spine.
In a new study from UC San Diego School of Medicine, thousands of fake social media posts tied to COVID-19 and financial scams are found on two popular platforms.
